These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33317908)

  • 41. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
    Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
    Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
    van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
    Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis.
    Modh A; Ghanem AI; Burmeister C; Hanna RK; Elshaikh MA
    Int J Gynecol Cancer; 2018 Feb; 28(2):248-253. PubMed ID: 29240603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does MMR status in endometrial cancer influence response to adjuvant therapy?
    Kim SR; Pina A; Albert A; McAlpine J; Wolber R; Blake Gilks C; Kwon JS
    Gynecol Oncol; 2018 Oct; 151(1):76-81. PubMed ID: 30172479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
    Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
    Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Geographic variation in the use of lymphadenectomy and external-beam radiotherapy for endometrial cancer: a cross-sectional analysis of population-based data.
    White B; Nordin A; Fry A; Ahmad A; McPhail S; Roe C; Rous B; Smittenaar R; Shelton J
    BJOG; 2019 Nov; 126(12):1456-1465. PubMed ID: 31449731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxicity after adjuvant therapy for stage III uterine cancer.
    Chen LC; Huang Y; Hou JY; Khoury-Collado F; Melamed A; St Clair CM; Tergas AI; Hur C; Hillyer GC; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Dec; 159(3):737-743. PubMed ID: 33008633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.
    Shigeta S; Nagase S; Mikami M; Ikeda M; Shida M; Sakaguchi I; Ushioda N; Takahashi F; Yamagami W; Yaegashi N; Udagawa Y; Katabuchi H
    J Gynecol Oncol; 2017 Nov; 28(6):e76. PubMed ID: 29027394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study.
    Versluis MAC; Pielsticker C; van der Aa MA; de Bruyn M; Hollema H; Nijman HW
    Oncology; 2018; 95(2):100-108. PubMed ID: 29791913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The nature of early-stage endometrial cancer recurrence-A national cohort study.
    Jeppesen MM; Jensen PT; Gilså Hansen D; Iachina M; Mogensen O
    Eur J Cancer; 2016 Dec; 69():51-60. PubMed ID: 27816832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer.
    Signorelli M; Lissoni AA; De Ponti E; Grassi T; Ponti S; Fruscio R
    J Gynecol Oncol; 2015 Oct; 26(4):284-92. PubMed ID: 26197768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.
    Mitamura T; Watari H; Todo Y; Kato T; Konno Y; Hosaka M; Sakuragi N
    J Gynecol Oncol; 2014 Oct; 25(4):301-5. PubMed ID: 25142623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.
    Zuurendonk LD; Smit RA; Mol BW; Feijen HW; de Graaff J; Sykora D; de Winter KA; vd Wurff A; Snijders MP; Kruitwagen RF
    Eur J Surg Oncol; 2006 May; 32(4):450-4. PubMed ID: 16546343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
    Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
    Feng W; Hua K; Malpica A; Zhou X; Baak JP
    Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.